Genting Singapore stock slips as STI hits record — what investors watch next
23 January 2026
1 min read

Genting Singapore stock slips as STI hits record — what investors watch next

Singapore, Jan 23, 2026, 15:31 SGT — Regular session.

  • In afternoon trading, Genting Singapore shares slipped 0.7% to S$0.725
  • Stock underperformed despite STI hitting an intraday high, driven by robust bank gains
  • Upcoming triggers to watch: MAS policy statement on Jan 29 and Genting’s full-year results on Feb 24

Shares of Genting Singapore Limited (SGX: G13) slipped 0.7% to S$0.725 by 3:10 p.m. on Friday, after bouncing between S$0.725 and S$0.735 earlier in the session. Trading volume hit 27.7 million shares, outpacing the stock’s one-week average. Its 52-week trading range remains between S$0.660 and S$0.800. 1

The slip happened even as the Straits Times Index touched an intraday high of 4,895.15 points, buoyed by record gains in major lenders UOB and OCBC. Macquarie analyst Jayden Vantarakis noted in a report that Singapore banks might see a boost from wealth inflows, thanks to the city-state’s reputation as a “safe-haven,” the Business Times said. 2

Genting Singapore is gearing up to report its full-year results for 2025 on Feb. 24, after the market closes. This comes as Singapore’s core inflation climbed 1.2% in December and the central bank readies a policy announcement scheduled for Jan. 29. 3

The counter ended Thursday up 0.7% at S$0.73, maintaining its narrow trading range in recent sessions. 4

Short selling picked up pace in the last session. Roughly 53.8% of the volume traded on Thursday was tagged as short sales—investors borrowing shares to sell now, wagering prices will drop. This activity put Genting Singapore among the SGX’s most shorted stocks by volume ratio, according to data from the exchange’s daily short sell report. 5

Genting Singapore runs Resorts World Sentosa, one of just two casino resorts in the city-state. Investors usually keep an eye on gaming volume, hotel occupancy, and non-gaming spending for early hints of momentum.

The setup cuts both ways. If visitor spending dips or operating costs rise, margins could come under pressure. Even if revenues stay steady, a sharp increase in resort spending could still cloud the earnings outlook.

Outside Singapore, risk appetite is still unsettled. Asian shares nudged higher following the Bank of Japan’s decision to hold rates steady. Invesco strategist David Chao labeled the BOJ’s stance as “hawkish.” 6

Local traders are eyeing the MAS policy statement set for Jan. 29. Then, attention will shift to Genting Singapore’s full-year results on Feb. 24, where management’s comments on demand and costs will be under close scrutiny.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Sembcorp share price edges up as Alinta vote nears — what SGX traders watch next
Previous Story

Sembcorp share price edges up as Alinta vote nears — what SGX traders watch next

India’s Q3 results rush: IndusInd Bank profit seen plunging as JSW Steel, BPCL, Cipla report today
Next Story

India’s Q3 results rush: IndusInd Bank profit seen plunging as JSW Steel, BPCL, Cipla report today

Go toTop